INTRODUCTION {#sec1-1}
============

The classification and the terminologies used for various vascular lesions have been very confusing despite the fact that a biological classification was first published in 1982 by Mulliken and Glowacki.\[[@ref1]\] This classification was later adopted by the International Society for the Study of Vascular Anomalies (ISSVA) in their first workshop held in Rome during June 1996.\[[@ref2]\] This continuing workshop now takes place every 2 years in various countries around the world. The ISSVA is an organization comprising of specialists in various disciplines interested in vascular anomalies and was founded in 1992 in Budapest with the aim of achieving consensus among health care professionals on the terminology, to further the knowledge of pathogenesis, diagnosis and treatment of these vascular lesions.\[[@ref3]\] An analysis of various scientific articles and latest edition of text books showed that significant confusion still prevails due to the indiscriminate, inappropriate and interchangeable use of various terms.\[[@ref3]\]

Classification {#sec2-1}
--------------

Historically benign vascular tumors were classified: (1) According to the type of fluid they contained as hemangioma (blood-containing lesion) and lymphangioma (lymph-containing lesion) and (2) according to the size of the vascular channels as capillary (small diameter vascular channels) and cavernous (large diameter vascular channels).\[[@ref4]\] Mulliken and Glowacki described a biological classification based on endothelial cell characteristics, physical findings and natural history, that differentiates vascular lesions with endothelial cell proliferation (example hemangioma) from lesions with structural anomalies (vascular malformations).\[[@ref1][@ref2][@ref3][@ref4][@ref5]\] The ISSVA modified it in their continuing workshops, differentiating vascular tumors from vascular malformations based on their clinical appearance, radiological features, pathological features and biological behaviour \[[Table 1](#T1){ref-type="table"}\].\[[@ref2][@ref3][@ref5]\]

###### 

Modified International Society for the Study of Vascular Anomalies (ISSVA) classification
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DISCUSSION {#sec1-2}
==========

Hemangiomas grow by endothelial cell hyperplasia and should be differentiated from vascular malformations, which are not true neoplasms but are localized defects of vascular morphogenesis caused by dysfunction in embryogenesis and vasculogenesis \[[Table 2](#T2){ref-type="table"}\].\[[@ref2][@ref3][@ref4][@ref5][@ref6][@ref7][@ref8][@ref9][@ref10]\] The Greek suffix "oma" means cellular proliferation of a tumor and thus the term hemangioma is erroneous when used for malformations.\[[@ref2]\] Hemangiomas are the most common benign soft tissue tumor of infancy and childhood, occurring in 12% of all infants and are found in greater frequency in girls, whites, premature infants, twins and are usually born to mothers of higher maternal age.\[[@ref2][@ref3][@ref4][@ref5][@ref6][@ref7][@ref8]\] They occur most frequently in head and neck region (60%), followed by the trunk (25%) and the extremities (15%), which are grouped into Infantile Hemangiomas (IHs) and Congenital Hemangiomas (CHs).\[[@ref2][@ref3][@ref8]\]

###### 

Differences between infantile hemangioma and vascular malformations
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IHs (outdated term juvenile hemangioma) arises during the first 8 weeks of life as an area of discoloration or telangiectasia. The lesion exhibits a rapid proliferative phase during early childhood for 6-12 months and grows into a raised rubbery bright-red tumor (resembling a strawberry, hence outdated term strawberry hemangioma).\[[@ref4][@ref5][@ref7][@ref8]\] This is followed by gradual involution and a spontaneous regression by the age of 5-9 years. 50% of all hemangiomas will completely involute by the age of 5 years and 90% by the age of 9 years.\[[@ref4][@ref5][@ref7][@ref8]\] 40% of involuted lesions may either show scaring, wrinkling, telangiectasia, or loose fibro-fatty tissue.\[[@ref5][@ref6][@ref8]\] IHs can be grouped into focal, segmental and indeterminate, or depending on the depth of the lesion from the skin surface as superficial, deep and mixed. Focal IHs are the most common variant, appearing as localized raised tumor-like lesion that tends to occur at the area of embryological fusion. Segmental IHs are flat plaque-like larger lesions that show a geographic segmental distribution and Indeterminate IHs shows characteristics of both focal and segmental IHs.\[[@ref5]\] Color varies with the depth of the lesion; they can be bright red (superficial), purple, blue, or normal skin colour (deep).\[[@ref3][@ref4][@ref5]\]

CHs are clinically present as fully developed lesions at birth and either rapidly involutes during the first year of life or may never show involution. These lesions do not exhibit a proliferative phase and do not grow after birth.\[[@ref5][@ref6]\] Rapidly Involuting Congenital Hemangiomas (RICH) are present at birth, either as red-purple color plaques with coarse telangiectasia, or as flat violaceous lesions, or as a raised greyish tumor surrounded by a pale halo with multiple tiny telangiectasia. RICH undergo a rapid regression phase and completely disappear by 12-18 months of age.\[[@ref5][@ref6]\] Non Involuting Congenital Hemangiomas (NICH) are also present at birth, appearing as pink or purple colored plaque-like lesions with prominent overlying coarse telangiectasia and peripheral blanching. NICH do not show a regression phase and grows proportionately with the growth of the child.\[[@ref5][@ref6]\] Main differences between congenital and infantile hemangiomas are summarised in [Table 3](#T3){ref-type="table"}.\[[@ref2][@ref4][@ref5][@ref6][@ref7][@ref10]\]

###### 

Differences between congenital and infantile hemangioma
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Apart from hemangiomas of soft tissue, scientific literatures have reported central hemangiomas (hemangioma of bone) and intramuscular hemangiomas. Many researchers in addition to the World Health Organization (WHO) believe that most if not all such proposed lesions are vascular malformations rather than true neoplasms.\[[@ref9]\] ISSVA classification has not been applied for the categorization of these osseous vascular lesions.\[[@ref9]\]

CONCLUSION {#sec1-3}
==========

Therapeutic guidelines, management and follow-up of hemangiomas and vascular malformations differ and are beyond the scope of this article. A good classification is important for categorising information, recording data, proper communication, guiding treatment plans, obtaining prognostic information and should be easy to understand and applied by the clinicians. It is our duty to be consistent in our terminology and classification of vascular lesions in all our scientific writings and presentations in order to communicate effectively, understand its pathophysiology, promote research and develop newer therapeutics. Terms to be avoided when describing these lesions include angioma, birthmarks, capillary hemangioma, cavernous hemangioma, juvenile hemangioma, strawberry hemangioma and inappropriate interchangeable use of the terms hemangioma and vascular malformation.
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